Darkside of Medicine
Teratogenic Medication
Teratogenic medicines are drugs that can cause harm to a developing baby during pregnancy. These medicines have the potential to interfere with normal growth and development before birth, and their use requires clear communication, strong safeguards, and informed decision‑making.
While many medicines are safe during pregnancy, many are medically necessary; those known to carry teratogenic risks must only be prescribed when no safer alternative exists and when patients are fully informed.
How Teratogenic Medicines Can Affect Pregnancy
Key Risks
Exposure to teratogenic medicines during pregnancy can increase the likelihood of:
-
Birth defects (e.g., heart abnormalities, cleft palate, limb differences)
-
Growth restrictions (babies smaller than expected)
-
Neurodevelopmental conditions (learning difficulties, autism, ADHD)
-
Pregnancy complications, including miscarriage or stillbirth
The understanding of the effects of teratogens is still growing; it is important to talk to your doctor about your medication if you are planning to become pregnant.
For a comprehensive list of teratogenic medicines, visit the website of UKTIS https://uktis.org
Why Awareness Matters
Advocacy Spotlight
Too many women and families are still not given clear, accessible information about the risks of teratogenic medicines.
Raising awareness ensures that:
-
Women and families can make fully informed decisions
-
Healthcare professionals consider safer alternatives
-
Society recognises the long‑term impact of avoidable harm
Awareness is not only a clinical issue, but it is also a matter of patient rights, transparency, and justice.
Protecting Future Generations
Preventing avoidable harm requires:
-
Stronger safety measures and prescribing safeguards
-
Better education for healthcare professionals
-
Full transparency for patients
-
Support for families already affected
By sharing accurate information and advocating for safer practices, we can help protect future generations and ensure that no family faces preventable harm.
📢 Call to Action: Stand With Us to Prevent Avoidable Harm
Every family deserves clear information, safe treatment, and protection from preventable risks.
Your voice can help drive change.
-
Mandatory, consistent communication of teratogenic risks
-
Stronger pregnancy‑prevention programmes
-
Improved training for healthcare professionals
-
National support services for affected families
-
Greater accountability and transparency across the healthcare system
Teratogenic Groups
Metabolism
Metabolic teratogens are substances or conditions that disrupt normal fetal development by altering the metabolic environment of the embryo or fetus. These disruptions often result from maternal metabolic disorders or exposures to certain drugs or chemicals that interfere with the mother's metabolic processes. When this interference occurs during pregnancy, especially in the first trimester, when organ systems are forming, it can lead to birth defects or developmental abnormalities.
Metabolic conditions like diabetes and thyroid disorders are teratogenic disorders that can harm foetal development. Malnutrition deprives the foetus of essential nutrients, while diabetes can cause foetal malformations due to abnormal blood sugar levels. Hypoglycaemia affects foetal heart proteins, and excessive blood sugar can lead to neural tube defects and free radical damage. According to a Canadian review (1990–2005), infants of diabetic mothers have a 4–10% risk of major malformations, two to three times higher than in the general population.
Thyroid disorders disrupt hormone production, causing risks like miscarriage, placental abruption, preterm labour, and lower IQ in
children. in the 1940s, experiments by Josef Warkany showed that tnyroid dysfunction in pregnant rats led to malformations in off spring.
Unlike direct-acting teratogens (like some infections or radiation), metabolic teratogens typically:
-
Alter the mother's metabolism
-
Disrupt nutrient delivery or waste removal
-
Cause toxic accumulation of metabolic byproducts
-
Affect critical processes like DNA synthesis, cell division, or protein formation
Drug-Induced Metabolic Teratogens
Certain medications alter maternal or fetal metabolism in ways that lead to teratogenic effects:
-
Valproic acid (sodium valproate): Alters folate metabolism; associated with neural tube defects, autism spectrum disorders, and facial dysmorphisms.
-
Methotrexate: Interferes with folate metabolism; causes multiple congenital abnormalities.
-
Warfarin: Disrupts vitamin K-dependent metabolic pathways; causes skeletal and CNS malformations.